261 related articles for article (PubMed ID: 17889386)
1. Late course accelerated hyperfractionated radiotherapy of nasopharyngeal carcinoma (LCAF).
He XY; Liu TF; He SQ; Huan SL; Pan ZQ
Radiother Oncol; 2007 Oct; 85(1):29-35. PubMed ID: 17889386
[TBL] [Abstract][Full Text] [Related]
2. A phase III study of late course accelerated hyperfractionated radiotherapy versus conventionally fractionated radiotherapy in patients with nasopharyngeal carcinoma.
Pan ZQ; He XY; Guo XM; Ye M; Zhang Z; He SQ; Liu TF
Am J Clin Oncol; 2012 Dec; 35(6):600-5. PubMed ID: 22134512
[TBL] [Abstract][Full Text] [Related]
3. Late-course accelerated hyperfractionated radiotherapy for localized esophageal carcinoma.
Zhao KL; Shi XH; Jiang GL; Wang Y
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):123-9. PubMed ID: 15337547
[TBL] [Abstract][Full Text] [Related]
4. Hyperfractionated radiotherapy in locally advanced nasopharyngeal cancer. An analysis of 43 consecutive patients.
Jereczek-Fossa BA; Morra A; DeBraud F; Alterio D; Mazzetta C; Rocca A; Catalano G; Bianchi L; Pasetti M; Chiesa F; Bruschini R; Orecchia R
Strahlenther Onkol; 2004 Jul; 180(7):425-33. PubMed ID: 15241530
[TBL] [Abstract][Full Text] [Related]
5. Late course accelerated hyperfractionated radiotherapy plus concurrent chemotherapy for squamous cell carcinoma of the esophagus: a phase III randomized study.
Zhao KL; Shi XH; Jiang GL; Yao WQ; Guo XM; Wu GD; Zhu LX
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1014-20. PubMed ID: 15990003
[TBL] [Abstract][Full Text] [Related]
6. Why to start the concomitant boost in accelerated radiotherapy for advanced laryngeal cancer in week 3.
Terhaard CH; Kal HB; Hordijk GJ
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):62-9. PubMed ID: 15850903
[TBL] [Abstract][Full Text] [Related]
7. Prospective phase II trial of concomitant boost radiotherapy for stage II nasopharyngeal carcinoma.
Lu JJ; Kong L; Shakespeare TP; Loh KS; Zhang Q; Tan KS; Lee KM
Oral Oncol; 2008 Jul; 44(7):703-9. PubMed ID: 18061528
[TBL] [Abstract][Full Text] [Related]
8. Treatment outcome of patients with stages I-II nasopharyngeal carcinoma after late course accelerated hyperfractionation radiotherapy alone.
He X; Ye M; Guo X; Pan Z; Zhang Z; He S; Liu T
Oral Oncol; 2012 Oct; 48(10):1058-1063. PubMed ID: 22658301
[TBL] [Abstract][Full Text] [Related]
9. [Simultaneous modulated accelerated radiation therapy in the treatment of nasopharyngeal cancer].
Xie CY; Wu SX; Jin XC; Yu JY; Wang JH; Li WF; Zhang P
Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(34):2412-5. PubMed ID: 18036320
[TBL] [Abstract][Full Text] [Related]
10. A randomised trial of accelerated radiotherapy for localised invasive bladder cancer.
Horwich A; Dearnaley D; Huddart R; Graham J; Bessell E; Mason M; Bliss J
Radiother Oncol; 2005 Apr; 75(1):34-43. PubMed ID: 15878099
[TBL] [Abstract][Full Text] [Related]
11. Nasopharyngeal carcinoma with cranial nerve palsy: the importance of MRI for radiotherapy.
Chang JT; Lin CY; Chen TM; Kang CJ; Ng SH; Chen IH; Wang HM; Cheng AJ; Liao CT
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1354-60. PubMed ID: 16297716
[TBL] [Abstract][Full Text] [Related]
12. Five year results of a randomized trial comparing hyperfractionated to conventional radiotherapy over four weeks in locally advanced head and neck cancer.
Cummings B; Keane T; Pintilie M; Warde P; Waldron J; Payne D; Liu FF; Bissett R; McLean M; Gullane P; O'Sullivan B
Radiother Oncol; 2007 Oct; 85(1):7-16. PubMed ID: 17920715
[TBL] [Abstract][Full Text] [Related]
13. Results of a prospective randomised trial comparing conventional radiotherapy to split course bifractionated radiation therapy in patients with nasopharyngeal carcinoma.
Daoud J; Toumi N; Siala W; Ghorbel A; Drira MM; Frikha M
Radiother Oncol; 2007 Oct; 85(1):17-23. PubMed ID: 17343938
[TBL] [Abstract][Full Text] [Related]
14. Sequential external beam radiotherapy and high-dose-rate intracavitary brachytherapy in T1 and T2 nasopharyngeal carcinoma: an evaluation of long-term outcome.
Thiagarajan A; Lin K; Tiong CE; Tan LK; Loh TK; Goh BC; Lu JJ
Laryngoscope; 2006 Jun; 116(6):938-43. PubMed ID: 16735885
[TBL] [Abstract][Full Text] [Related]
15. Radiotherapy for high-grade gliomas. Does altered fractionation improve the outcome?
Nieder C; Andratschke N; Wiedenmann N; Busch R; Grosu AL; Molls M
Strahlenther Onkol; 2004 Jul; 180(7):401-7. PubMed ID: 15241527
[TBL] [Abstract][Full Text] [Related]
16. Prognostic impact of primary tumor volume in patients with nasopharyngeal carcinoma treated by definitive radiation therapy.
Shen C; Lu JJ; Gu Y; Zhu G; Hu C; He S
Laryngoscope; 2008 Jul; 118(7):1206-10. PubMed ID: 18418278
[TBL] [Abstract][Full Text] [Related]
17. SMART (simultaneous modulated accelerated radiotherapy) for locally advanced nasopharyngeal carcinomas.
Koom WS; Kim TH; Shin KH; Pyo HR; Kim JY; Kim DY; Yoon M; Park SY; Lee DH; Ryu JS; Jung YS; Lee SH; Cho KH
Head Neck; 2008 Feb; 30(2):159-69. PubMed ID: 17764088
[TBL] [Abstract][Full Text] [Related]
18. Prospective phase II trial of concomitant boost radiotherapy for stage II nasopharyngeal carcinoma: an evaluation of response and toxicity.
Lu JJ; Shakespeare TP; Thiagarajan A; Zhang X; Liang L; Tan S
Laryngoscope; 2005 May; 115(5):806-10. PubMed ID: 15867644
[TBL] [Abstract][Full Text] [Related]
19. Hyperfractionated radiation therapy for locoregionally advanced nasopharyngeal cancer.
Isobe K; Uno T; Kawakami H; Ueno N; Aruga T; Yasuda S; Hanazawa T; Okamoto Y; Ito H; Shigematsu N
Jpn J Clin Oncol; 2005 Mar; 35(3):116-20. PubMed ID: 15741300
[TBL] [Abstract][Full Text] [Related]
20. Major late toxicities after conformal radiotherapy for nasopharyngeal carcinoma-patient- and treatment-related risk factors.
Lee AW; Ng WT; Hung WM; Choi CW; Tung R; Ling YH; Cheng PT; Yau TK; Chang AT; Leung SK; Lee MC; Bentzen SM
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1121-8. PubMed ID: 18723296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
